Amarin Corp Plc (AMRN)

[Whalatane]

Bouf. There is IMHO almost zero risk re approval in the EU . It will be approved . Vascepa is a very safe drug and there’s obviously a medical need.

As to timing ... there is some speculation that AMRN will “ slow walk “ the approval .... delaying as long as possible the start of the 10 yr EU exclusivity .... hoping to have the appeals decision before they finally sign off on terms / plans for the EU .

AMRN had stated previously they would announce which path to pursue ... sell rights , partner / royalty sales or a hybrid ... in Q3

The most conservative estimate I have read re EU value ( royalty payments only ) is about 40% above where AMRN currently trades

Kiwi